New blood clot drug tested in healthy volunteers
NCT ID NCT06517563
First seen Sep 30, 2025 · Last updated May 19, 2026 · Updated 30 times
Summary
This early-stage study tested a new drug called VMX-C001 in 16 healthy adults to see how it interacts with common blood thinners like heparin and rivaroxaban. The goal was to measure changes in blood clotting time, not to treat any disease. The study is complete and provides safety and dosing information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COAGULATION DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ICON
Groningen, 9728 NZ, Netherlands
Conditions
Explore the condition pages connected to this study.